Table 2 Characteristics of the 379 patients included in the study.

From: Association of Alk1 and Endoglin Polymorphisms with Cardiovascular Damage

 

N

%

Male

201

53.0

Hypertension

277

73.1

Diabetes mellitus

88

23.2

Target organ damage

175

46.2

Altered basal glycaemia

45

11.9

BMI <25

67

17.7

BMI 25-30

197

52.0

BMI >30

115

30.3

Dyslipidaemia

259

68.3

Elevated PP

92

24.3

LVH

69

18.2

C-IMT

67

17.7

Altered PWV

58

15.3

PAD

6

1.6

CV risk <1%

53

14.0

CV risk 1–5%

181

47.8

CV risk 5–10%

78

20.6

CV risk >10%

67

17.7

Antihypertensive drugs

210

55.4

Antidiabetic drugs

61

16.1

Lipid-lowering drugs

149

39.3

  1. BMI: body mass index; C-IMT: carotid intima media thickness; CV: cardiovascular; HT: hypertension; LVH: left ventricular hypertrophy; PAD: peripheral arterial disease; PP: pulse pressure; PWV: pulse wave velocity.
Back to article page